KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Capital Leases (2019 - 2025)

Opko Health's Capital Leases history spans 6 years, with the latest figure at $3.4 million for Q4 2025.

  • For Q4 2025, Capital Leases fell 16.49% year-over-year to $3.4 million; the TTM value through Dec 2025 reached $3.4 million, down 16.49%, while the annual FY2025 figure was $3.4 million, 16.49% down from the prior year.
  • Capital Leases reached $3.4 million in Q4 2025 per OPK's latest filing, up from $3.4 million in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $7.7 million in Q3 2023 to a low of $3.4 million in Q3 2025.
  • Average Capital Leases over 4 years is $5.1 million, with a median of $4.6 million recorded in 2024.
  • Peak YoY movement for Capital Leases: rose 2.61% in 2023, then tumbled 44.13% in 2024.
  • A 4-year view of Capital Leases shows it stood at $7.1 million in 2022, then grew by 2.61% to $7.3 million in 2023, then tumbled by 44.13% to $4.1 million in 2024, then decreased by 16.49% to $3.4 million in 2025.
  • Per Business Quant, the three most recent readings for OPK's Capital Leases are $3.4 million (Q4 2025), $3.4 million (Q3 2025), and $3.7 million (Q2 2025).